John Macgregor, MD, PhD

Professor

Dr. John S. MacGregor is a cardiologist and an interventional cardiologist. He received his medical degree from Cornell University Medical College, where he was in the Medical Scientist Training Program (MSTP). As part of the MSTP he also earned a Ph.D. in biochemistry. After receiving his M.D. and Ph.D. degrees, Dr. MacGregor did research at Rockefeller University, followed by internal medicine training at the University of California San Diego, and finally cardiology and interventional cardiology training at the University of California San Francisco (UCSF).

Since completing his training, Dr. MacGregor has been on the faculty of UCSF where he is currently a Professor of Medicine. Since 1991 he has been the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at San Francisco General Hospital. His main area of interest is the endovascular treatment of coronary artery disease.
Education
Post-Doc Fellow/Scholar, 1991 - Medicine, University of California, San Francisco
Residency, - Cardiology, University of California, San Francisco
Publications
  1. Echocardiographic determination of pulmonary arterial capacitance.
  2. Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.
  3. Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry.
  4. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry.
  5. Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
  6. Biliary cardiac tamponade as a result of iatrogenic biliary-pericardial fistula.
  7. Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis.
  8. Comparison of procedural success and long-term outcomes of stent thrombosis in coronary bypass grafts versus native coronary arteries.
  9. Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound.
  10. Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients.
  11. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.
  12. Electrocardiographic criteria for ST-elevation myocardial infarction in patients with left ventricular hypertrophy.
  13. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry.
  14. Delaying primary percutaneous coronary intervention for computed tomographic scans in the emergency department.
  15. Angiographic stent thrombosis at coronary bifurcations: short- and long-term prognosis.
  16. Improvement in revascularization time after creation of a coronary catheterization laboratory at a public hospital.
  17. Predictors of depressed left ventricular function in patients presenting with ST-elevation myocardial infarction.
  18. Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry.
  19. Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death.
  20. Cholesterol-based pericardial effusion and aortic thromboembolism in a 9-year-old mixed-breed dog with hypothyroidism.
  21. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection.
  22. Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia.
  23. Cardiovascular involvement in AIDS.
  24. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.
  25. Percutaneous valvuloplasty to relieve stenosis of a bioprosthetic tricuspid valve in a patient with bacterial endocarditis.
  26. Differential contribution of nitric oxide to regulation of vascular tone in coronary conductance and resistance arteries: intravascular ultrasound studies.
  27. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound.
  28. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
  29. Pleuritic chest pain in a postpartum woman.
  30. Transvenous coronary ultrasound imaging. A novel approach to visualization of the coronary arteries.
  31. Diagnosis and management of infective endocarditis.